Literature DB >> 14482545

Massive niacin treatment in schizophrenia. Review of a nine-year study.

H OSMOND, A HOFFER.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/therapy; SCHIZOPHRENIA/therapy

Mesh：

Substances：

Year:  1962        PMID： 14482545     DOI： 10.1016/s0140-6736(62)91259-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Regulation of NAD+ metabolism in aging and disease.

Authors:  Xiaogang Chu; Raghavan Pillai Raju
Journal:  Metabolism       Date:  2021-10-28       Impact factor: 8.694

Review 2.  Vitamins in psychiatry. Do they have a role?

Authors:  W M Petrie; T A Ban
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 3.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

4.  Acute effects of nicotinic acid on hepatic transport of 99mTc-PIPIDA.

Authors:  R B Shafer; R G Knodell; L N Stanley; M K Elson
Journal:  Eur J Nucl Med       Date:  1983

Review 5.  Neuropsychiatric consequences of cardiovascular medications.

Authors:  Jeff C Huffman; Theodore A Stern
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.

Authors:  W Todd Penberthy
Journal:  PPAR Res       Date:  2009-05-17       Impact factor: 4.964

7.  Natural Medicines for Psychotic Disorders: A Systematic Review.

Authors:  H J Rogier Hoenders; Agna A Bartels-Velthuis; Nina K Vollbehr; Richard Bruggeman; Henderikus Knegtering; Joop T V M de Jong
Journal:  J Nerv Ment Dis       Date:  2018-02       Impact factor: 2.254

8.  Nicotinic Acid Long-Term Effectiveness in a Patient with Bipolar Type II Disorder: A Case of Vitamin Dependency.

Authors:  Bo H Jonsson
Journal:  Nutrients       Date:  2018-01-27       Impact factor: 5.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.